Lixte Stock Market Value

LIXT -  USA Stock  

USD 2.07  0.07  3.50%

Lixte Biotech's market value is the price at which a share of Lixte Biotech stock trades on a public exchange. It measures the collective expectations of Lixte Biotech Hlds investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Lixte Biotech Hlds and determine expected loss or profit from investing in Lixte Biotech over a given investment horizon. Additionally, see Lixte Biotech Hype Analysis, Lixte Biotech Correlation, Lixte Biotech Valuation, Lixte Biotech Volatility, as well as analyze Lixte Biotech Alpha and Beta and Lixte Biotech Performance.

The market value of Lixte Biotech Hlds is measured differently than its book value, which is the value of Lixte that is recorded on the company's balance sheet. Investors also form their own opinion of Lixte Biotech's value that differs from its market value or its book value, called intrinsic value, which is Lixte Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lixte Biotech's market value can be influenced by many factors that don't directly affect Lixte Biotech Hlds underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lixte Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Lixte Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lixte Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Lixte Biotech 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lixte Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lixte Biotech.
No Change 0.00  0.0 
In 6 months and 30 days
If you would invest  0.00  in Lixte Biotech on February 24, 2021 and sell it all today you would earn a total of 0.00 from holding Lixte Biotech Hlds or generate 0.0% return on investment in Lixte Biotech over 210 days. Lixte Biotech is related to or competes with Alnylam Pharmaceuticals, Seagen, Regeneron Pharmaceuticals, Beigene, and Vertex Pharmaceutic. Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzym...

Lixte Biotech Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lixte Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lixte Biotech Hlds upside and downside potential and time the market with a certain degree of confidence.

Lixte Biotech Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Lixte Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lixte Biotech's standard deviation. In reality, there are many statistical measures that can use Lixte Biotech historical prices to predict the future Lixte Biotech's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Lixte Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Lixte Biotech in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Lixte Biotech. Your research has to be compared to or analyzed against Lixte Biotech's peers to derive any actionable benefits. When done correctly, Lixte Biotech's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Lixte Biotech Hlds.

Lixte Biotech Hlds Backtested Returns

Lixte Biotech Hlds has Sharpe Ratio of -0.12, which conveys that the firm had -0.12% of return per unit of risk over the last 3 months. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Lixte Biotech exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Lixte Biotech Hlds mean deviation of 2.92, and Risk Adjusted Performance of (0.08) to check out the risk estimate we provide.
The company secures a Beta (Market Risk) of 1.8308, which conveys a somewhat significant risk relative to the market. Let's try to break down what Lixte's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lixte Biotech will likely underperform. Even though it is essential to pay attention to Lixte Biotech Hlds price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Lixte Biotech exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Lixte Biotech Hlds has an expected return of -0.49%. Please be advised to verify Lixte Biotech Hlds treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price to decide if Lixte Biotech Hlds performance from the past will be repeated at some point in the near future.
AdviceVolatility TrendExposureCorrelations



Good predictability

Lixte Biotech Hlds has good predictability. Overlapping area represents the amount of predictability between Lixte Biotech time series from 24th of February 2021 to 9th of June 2021 and 9th of June 2021 to 22nd of September 2021. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lixte Biotech Hlds price movement. The serial correlation of 0.66 indicates that around 66.0% of current Lixte Biotech price fluctuation can be explain by its past prices.
Correlation Coefficient0.66
Spearman Rank Test0.67
Residual Average0.0
Price Variance0.12

Lixte Biotech Hlds lagged returns against current returns

Autocorrelation, which is Lixte Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lixte Biotech's stock expected returns. We can calculate the autocorrelation of Lixte Biotech returns to help us make a trade decision. For example, suppose you find that Lixte Biotech stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 

Lixte Biotech regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lixte Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lixte Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lixte Biotech stock over time.
 Current vs Lagged Prices 

Lixte Biotech Lagged Returns

When evaluating Lixte Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lixte Biotech stock have on its future price. Lixte Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lixte Biotech autocorrelation shows the relationship between Lixte Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Lixte Biotech Hlds.
 Regressed Prices 

Lixte Biotech Investors Sentiment

The influence of Lixte Biotech's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Lixte. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Current Sentiment - LIXT

Lixte Biotech Hlds Investor Sentiment

Macroaxis portfolio users are evenly split in their trading attitude regarding investing in Lixte Biotech Hlds. What is your trading attitude regarding investing in Lixte Biotech Hlds? Are you bullish or bearish?
50% Bullish
50% Bearish

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lixte Biotech Hlds using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see Lixte Biotech Hype Analysis, Lixte Biotech Correlation, Lixte Biotech Valuation, Lixte Biotech Volatility, as well as analyze Lixte Biotech Alpha and Beta and Lixte Biotech Performance. Note that the Lixte Biotech Hlds information on this page should be used as a complementary analysis to other Lixte Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for Lixte Stock analysis

When running Lixte Biotech Hlds price analysis, check to measure Lixte Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lixte Biotech is operating at the current time. Most of Lixte Biotech's value examination focuses on studying past and present price action to predict the probability of Lixte Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lixte Biotech's price. Additionally, you may evaluate how the addition of Lixte Biotech to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Lixte Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Lixte Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Lixte Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...